Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom

Toronto, Ontario, December 15, 2020Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE:PSYC, OTCQB:DCNPF, FRANKFURT:5U9) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has successfully completed its first extraction of a legal psychedelic derived from Amanita Muscaria mushrooms.

The scientific team sourced dried Amanita Muscaria Mushroom caps from five separate suppliers from different geographic regions around the world. The dried Amanita was extracted using the Company’s proprietary extraction protocol and was then packaged and sent with samples of the raw materials to an independent lab. The lab will be testing the extract for the necessary and desired compounds with a goal of providing the Company with a report within 5-7 days. The report will allow Psyched to finalize the specifications for its flagship product, a pure, natural, and safe for human consumption Amanita Muscaria extract.

David Shisel, COO of the Company says, “Our scientific team is working around the clock to ensure we achieve these key milestones in a timely fashion. Once we finalize our specifications, we will be able to produce our first large-scale extraction that will be used for our pre-clinical trials, the accelerated stability tests and all of our scientific needs.